Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless - Reuters

Reuters | Jan. 28, 2026, 7:03 a.m. | Original
Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless Reuters
Breakingviews - Japan’s auto reckoning could start with Mazda - Reuters General Dynamics revenue rises on strong defense business - Reuters